Similar articles

• Chemotherapy for breast cancer.

  Allegra JC, Lippman ME. Allegra JC, et al. Compr Ther. 1979 Feb;5(2):13-7. Compr Ther. 1979. PMID: 428200
• Variations in responsiveness and survival of clinical subsets of patients with metastatic breast cancer to two chemotherapy combinations.

  Smalley RV, Bartolucci AA. Smalley RV, et al. Eur J Cancer (1965). 1980;Suppl 1:141-6. Eur J Cancer (1965). 1980. PMID: 7318861 No abstract available.
• Activity of adriamycin in metastatic breast cancer resistant to a combination regimen with cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prdnisone.

  Frederiksen PL, Joergensen ST, Roesdahl K, Thomsen J, Mouridsen HT. Frederiksen PL, et al. Cancer Treat Rep. 1978 Mar;62(3):449-50. Cancer Treat Rep. 1978. PMID: 348314 Clinical Trial. No abstract available.
• [Adjuvant chemotherapy in breast cancer].

  Senn HJ. Senn HJ. Dtsch Med Wochenschr. 1981 Nov 27;106(48):1626-30. doi: 10.1055/s-2008-1070568. Dtsch Med Wochenschr. 1981. PMID: 7030686 Review. German. No abstract available.
• Chemotherapy of skeletal metastases.

  Cadman E, Bertino JR. Cadman E, et al. Int J Radiat Oncol Biol Phys. 1976 Nov-Dec;1(11-12):1211-5. doi: 10.1016/0360-3016(76)90097-3. Int J Radiat Oncol Biol Phys. 1976. PMID: 62744 Review. No abstract available.